ZIVO Bioscience Announces Amended Convertible Debt Structure and …Marketwired (press release)Therefore, if the established price of the stock at the time of closing was 22 cents, the conversion price is also 22 cents, as are any warrants applicable to that transaction. The Company filed an 8-K on December 29, 2014 to more … “Our partners […]
ZIVO Bioscience Announces Amended Convertible Debt Structure and …MarketWatchTherefore, if the established price of the stock at the time of closing was 22 cents, the conversion price is also 22 cents, as are any warrants applicable to that transaction. The Company filed an 8-K on December 29, 2014 to more … “Our partners at …
ZIVO Bioscience Announces Amended Convertible Debt Structure and … – MarketWatch Read More »
BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About $13 MlnNasdaqThese holders have agreed to exercise their warrants in full, for a total of about 2.5 million shares of common stock, at an exercise price of $5.22 per share. This represents a 4 percent premium to the closing price of $5.03, and will generate
BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About $13 Mln – Nasdaq Read More »
StreetInsider.com (subscription)These holders have agreed to exercise their warrants in full (for a total of approximately 2.5 million shares of common stock) at an exercise price of $5.22 per share, a 4% premium to the closing price of $5.03, which will generate gross cash proceeds …BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About
BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About $13 MlnRTT NewsThese holders have agreed to exercise their warrants in full, for a total of about 2.5 million shares of common stock, at an exercise price of $5.22 per share. This represents a 4 percent premium to the closing price of $5.03, and will
BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About $13 Mln – RTT News Read More »
BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 …SYS-CON Media (press release)These holders have agreed to exercise their warrants in full (for a total of approximately 2.5 million shares of common stock) at an exercise price of $5.22 per share, a 4% premium to the closing price of $5.03, which will generate gross cash
BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 …CNNMoneyThese holders have agreed to exercise their warrants in full (for a total of approximately 2.5 million shares of common stock) at an exercise price of $5.22 per share, a 4% premium to the closing price of $5.03, which will generate gross cash proceeds … and
BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 … – CNNMoney Read More »
PR Newswire (press release)These holders have agreed to exercise their warrants in full (for a total of approximately 2.5 million shares of common stock) at an exercise price of $5.22 per share, a 4% premium to the closing price of $5.03, which will generate gross cash proceeds …BrainStorm Enters Into Warrant Exercise Deal For Proceeds
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for …Digital Journal… to exchange (“Offer to Exchange”) new shares of the Company’s common stock (“Shares”) for outstanding Company warrants to purchase up to 5,964,738 shares of common stock (the “Warrants“) (at a ratio of one Share for every three Warrants tendered). and more …read more
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for … – Digital Journal Read More »
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for …MarketWatchTo December 31, 2014, 5,915,598 Warrants have been exercised for total gross cash proceeds of approximately $3.9M. In addition, as of December 31, 2014, certain warrant holders had exchanged 1,244,666 Warrants for 414,889 new shares of common … and more …read more
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for … – MarketWatch Read More »